Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Acumen Pharmaceuticals IncCommon Stock stock | $13.93

Learn how to easily invest in Acumen Pharmaceuticals IncCommon Stock stock.

Acumen Pharmaceuticals Inc. Common Stock is a biotechnology business based in the US. Acumen Pharmaceuticals IncCommon Stock shares (ABOS) are listed on the NASDAQ and all prices are listed in US Dollars. Acumen Pharmaceuticals IncCommon Stock employs 7 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Acumen Pharmaceuticals IncCommon Stock

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ABOS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Acumen Pharmaceuticals IncCommon Stock stock price (NASDAQ: ABOS)

Use our graph to track the performance of ABOS stocks over time.

Acumen Pharmaceuticals IncCommon Stock shares at a glance

Information last updated 2021-10-10.
Latest market close$13.93
52-week range$13.41 - $26.98
50-day moving average $16.20
200-day moving average $16.48
Wall St. target price$25.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-216.79

Buy Acumen Pharmaceuticals IncCommon Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Acumen Pharmaceuticals IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Acumen Pharmaceuticals IncCommon Stock price performance over time

Historical closes compared with the close of $13.93 from 2021-10-14

1 week (2021-10-08) 3.57%
1 month (2021-09-16) -13.91%
3 months (2021-07-16) -22.00%
6 months (2021-04-12) N/A
1 year (2020-10-12) N/A
2 years (2019-10-12) N/A
3 years (2018-10-12) N/A
5 years (2016-10-12) N/A

Acumen Pharmaceuticals IncCommon Stock financials

Revenue TTM $1.1 million
Gross profit TTM $-6,561,000
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value N/A
Market capitalisation $544.3 million

TTM: trailing 12 months

Shorting Acumen Pharmaceuticals IncCommon Stock shares

There are currently 139,177 Acumen Pharmaceuticals IncCommon Stock shares held short by investors – that's known as Acumen Pharmaceuticals IncCommon Stock's "short interest". This figure is 1281.5% up from 10,074 last month.

There are a few different ways that this level of interest in shorting Acumen Pharmaceuticals IncCommon Stock shares can be evaluated.

Acumen Pharmaceuticals IncCommon Stock's "short interest ratio" (SIR)

Acumen Pharmaceuticals IncCommon Stock's "short interest ratio" (SIR) is the quantity of Acumen Pharmaceuticals IncCommon Stock shares currently shorted divided by the average quantity of Acumen Pharmaceuticals IncCommon Stock shares traded daily (recently around 198824.28571429). Acumen Pharmaceuticals IncCommon Stock's SIR currently stands at 0.7. In other words for every 100,000 Acumen Pharmaceuticals IncCommon Stock shares traded daily on the market, roughly 700 shares are currently held short.

To gain some more context, you can compare Acumen Pharmaceuticals IncCommon Stock's short interest ratio against those of similar companies.

However Acumen Pharmaceuticals IncCommon Stock's short interest can also be evaluated against the total number of Acumen Pharmaceuticals IncCommon Stock shares, or, against the total number of tradable Acumen Pharmaceuticals IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Acumen Pharmaceuticals IncCommon Stock's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Acumen Pharmaceuticals IncCommon Stock shares in existence, roughly 0 shares are currently held short) or 0.0101% of the tradable shares (for every 100,000 tradable Acumen Pharmaceuticals IncCommon Stock shares, roughly 10 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Acumen Pharmaceuticals IncCommon Stock.

Find out more about how you can short Acumen Pharmaceuticals IncCommon Stock stock.

Acumen Pharmaceuticals IncCommon Stock share dividends

We're not expecting Acumen Pharmaceuticals IncCommon Stock to pay a dividend over the next 12 months.

Acumen Pharmaceuticals IncCommon Stock overview

Acumen Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia. .

Frequently asked questions

What percentage of Acumen Pharmaceuticals IncCommon Stock is owned by insiders or institutions?
Currently 11.274% of Acumen Pharmaceuticals IncCommon Stock shares are held by insiders and 54.151% by institutions.
How many people work for Acumen Pharmaceuticals IncCommon Stock?
Latest data suggests 7 work at Acumen Pharmaceuticals IncCommon Stock.
When does the fiscal year end for Acumen Pharmaceuticals IncCommon Stock?
Acumen Pharmaceuticals IncCommon Stock's fiscal year ends in December.
Where is Acumen Pharmaceuticals IncCommon Stock based?
Acumen Pharmaceuticals IncCommon Stock's address is: 427 Park St., Charlottesville, VA, United States, 22902
What is Acumen Pharmaceuticals IncCommon Stock's ISIN number?
Acumen Pharmaceuticals IncCommon Stock's international securities identification number is: US00509G2093

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site